Table 6.
Recurrencen (%) | |
---|---|
No. of patients | 27 |
Median average age: years (range) | 34.6 (18–68) |
Median BMI:: kg/m2 (range) | 27.5 (18.6–45.2) |
Nulliparity | 17 (63) |
Menopause | 5 (18.5) |
CA-125 | |
Median average rate: UI/mL (range) | 1453 (15–21,624) |
Rate ≥ 35 | 17 (63) |
Anatomopathology | |
Serous tumor | 18 (66.7) |
Mucinous tumor | 9 (33.3) |
Peritoneal implants | 14 (51.9) |
Peritoneal implants invasive | 3 (11.1) |
Stage FIGO | |
FIGO 1 | 12 (44.4) |
FIGO ≥ 2 | 14 (51.9) |
Median average recurrence time: months (range) | 45.8 (1–264) |
Initial conservative treatment | 19 (70.4) |
History of chemotherapy | 6 (1.8) |
Recurrence surgery | 23 (85.2) |
BMI body-mass index, FIGO international federation of gynecology and obstetrics